JANSSEN-CILAG'S Remicade (infliximab) now has a second biosimilar competitor after Inflectra (from Pfizer's Hospira), in the form of Renflexis from MSD.
Biosimilar fact sheets for health professionals are at health.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Sep 17